Management Of Placenta Previa Cases And Determination Of Hospitalization Criteria

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04264234

Enrollment

Registered

2020-02-11

Start date

2018-11-13

Completion date

2020-02-01

Last updated

2022-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Previa

Keywords

placenta previa, placental invasion anomalies, timing of the birth

Brief summary

Placenta previa cases are one of the difficult groups of patients to manage in modern obstetrics. When the literature is evaluated extensively, no clear information can be seen especially in terms of hospitalization time. Inpatient follow-up of this patients has negative effects like hospital infections in terms of the patient, workload in terms of health personnel and financial losses in terms of the country's economy. Placenta previa cases are complicated patients in which generalizations cannot be easily performed and they should be monitored at third level hospitals. In addition, care should be personalized considering the many reasons. In this study, placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery. Thus, in this study, it was aimed to determine the parameters that would allow systematic personalization of health service in this particular patient group by making risk assessment of placenta previa cases.

Interventions

DIAGNOSTIC_TESTVaginal Ultrasonography

Placenta previa cases will be evaluated at 32nd week by vaginal ultrasonography for invasion anomaly and preterm birth.

DIAGNOSTIC_TESTMagnetic Resonance Imaging

Placenta previa cases will be evaluated at 32nd week by MRI for invasion anomaly and preterm birth.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Intervention model description

Placenta previa cases will be followed up at 28th gestational week and evaluated at 32nd week by vaginal ultrasonography and MRI and this follow-up will continue until delivery.

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* Monitoring of placenta previa * To apply before the 28th week * To have a low-risk second trimester screening test * No malformation detected in the anomaly screening

Exclusion criteria

* Multiple pregnancies * Pregnancy complicated with preeclampsia * Pregnancy complicated by gestational hypertension * Pregnancy complicated by gestational diabetes mellitus

Design outcomes

Primary

Measure	Time frame	Description
The number of placental invasion pathologies	1 day	Placental invasion pathologies detected during delivery will be evaluated.
The number of preterm birth	1 day	The relation between preterm birth and placental invasion pathologies will be assessed.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026